177 related articles for article (PubMed ID: 35436011)
1. Midbody plays an active role in fibroblast-myofibroblast transition by mediating TGF-β signaling.
Jung SW; Kim SM; Kim A; Park SH; Moon JY; Lee SH
FASEB J; 2022 May; 36(5):e22272. PubMed ID: 35436011
[TBL] [Abstract][Full Text] [Related]
2. WISP3 prevents fibroblast-myofibroblast transdifferentiation in NRK-49F cells.
Yi Y; Ma J; Jianrao L; Wang H; Zhao Y
Biomed Pharmacother; 2018 Mar; 99():306-312. PubMed ID: 29353205
[TBL] [Abstract][Full Text] [Related]
3. Lefty-1 alleviates TGF-β1-induced fibroblast-myofibroblast transdifferentiation in NRK-49F cells.
Zhang L; Zhang J; Xu C; Zhou X; Wang W; Zheng R; Hu W; Wu P
Drug Des Devel Ther; 2015; 9():4669-78. PubMed ID: 26316705
[TBL] [Abstract][Full Text] [Related]
4. Smad7 blocks transforming growth factor-β1-induced gingival fibroblast-myofibroblast transition via inhibitory regulation of Smad2 and connective tissue growth factor.
Sobral LM; Montan PF; Zecchin KG; Martelli-Junior H; Vargas PA; Graner E; Coletta RD
J Periodontol; 2011 Apr; 82(4):642-51. PubMed ID: 21054221
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of TRPC6 suppressed TGFβ-induced fibroblast-myofibroblast transdifferentiation in renal interstitial NRK-49F cells.
Jiang S; Gu L; Hu Y; Ren Y; Yang Z; Chai C; Yu B; Ge H; Cao Z; Zhao F
Exp Cell Res; 2022 Dec; 421(1):113374. PubMed ID: 36206825
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus induces fibroblast-to-myofibroblast transition via a TGF-β-dependent mechanism to contribute to renal fibrosis.
Ume AC; Wenegieme TY; Shelby JN; Paul-Onyia CDB; Waite AMJ; Kamau JK; Adams DN; Susuki K; Bennett ES; Ren H; Williams CR
Am J Physiol Renal Physiol; 2023 May; 324(5):F433-F445. PubMed ID: 36927118
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor β1 signaling coincides with epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis in mice.
Shen M; Liu X; Zhang H; Guo SW
Hum Reprod; 2016 Feb; 31(2):355-69. PubMed ID: 26689216
[TBL] [Abstract][Full Text] [Related]
8. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor β-1 stimulates profibrotic epithelial signaling to activate pericyte-myofibroblast transition in obstructive kidney fibrosis.
Wu CF; Chiang WC; Lai CF; Chang FC; Chen YT; Chou YH; Wu TH; Linn GR; Ling H; Wu KD; Tsai TJ; Chen YM; Duffield JS; Lin SL
Am J Pathol; 2013 Jan; 182(1):118-31. PubMed ID: 23142380
[TBL] [Abstract][Full Text] [Related]
10. MST1/2 in PDGFRα
An Y; Ren Y; Wang J; Zang J; Gao M; Wang H; Wang S; Dong Y
Am J Physiol Renal Physiol; 2022 May; 322(5):F512-F526. PubMed ID: 35253468
[TBL] [Abstract][Full Text] [Related]
11. Melatonin ameliorates renal fibroblast-myofibroblast transdifferentiation and renal fibrosis through miR-21-5p regulation.
Li N; Wang Z; Gao F; Lei Y; Li Z
J Cell Mol Med; 2020 May; 24(10):5615-5628. PubMed ID: 32243691
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated P311 ameliorates renal fibrosis through inhibition of epithelial-mesenchymal transition via TGF-β1-Smad-ILK pathway in unilateral ureteral obstruction rats.
Qi FH; Cai PP; Liu X; Si GM
Int J Mol Med; 2018 May; 41(5):3015-3023. PubMed ID: 29436600
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction.
Yang J; Dai C; Liu Y
Am J Pathol; 2003 Aug; 163(2):621-32. PubMed ID: 12875981
[TBL] [Abstract][Full Text] [Related]
14. Nupr1 mediates renal fibrosis via activating fibroblast and promoting epithelial-mesenchymal transition.
Zhou R; Liao J; Cai D; Tian Q; Huang E; Lü T; Chen SY; Xie WB
FASEB J; 2021 Mar; 35(3):e21381. PubMed ID: 33617091
[TBL] [Abstract][Full Text] [Related]
15. In vitro cultured fetal fibroblasts have myofibroblast-associated characteristics and produce a fibrotic-like environment upon stimulation with TGF-β1: Is there a thin line between fetal scarless healing and fibrosis?
Walraven M; Akershoek JJ; Beelen RH; Ulrich MM
Arch Dermatol Res; 2017 Mar; 309(2):111-121. PubMed ID: 28004279
[TBL] [Abstract][Full Text] [Related]
16. Corroborating evidence for platelet-induced epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis.
Liu X; Shen M; Qi Q; Zhang H; Guo SW
Hum Reprod; 2016 Apr; 31(4):734-49. PubMed ID: 26908845
[TBL] [Abstract][Full Text] [Related]
17. Deletion of FHL2 in fibroblasts attenuates fibroblasts activation and kidney fibrosis via restraining TGF-β1-induced Wnt/β-catenin signaling.
Duan Y; Qiu Y; Huang X; Dai C; Yang J; He W
J Mol Med (Berl); 2020 Feb; 98(2):291-307. PubMed ID: 31927599
[TBL] [Abstract][Full Text] [Related]
18. Effects of proteasome inhibitors on rat renal fibrosis in vitro and in vivo.
Sakairi T; Hiromura K; Takahashi S; Hamatani H; Takeuchi S; Tomioka M; Maeshima A; Kuroiwa T; Nojima Y
Nephrology (Carlton); 2011 Jan; 16(1):76-86. PubMed ID: 21175982
[TBL] [Abstract][Full Text] [Related]
19. 3-Bromopyruvate decreased kidney fibrosis and fibroblast activation by suppressing aerobic glycolysis in unilateral ureteral obstruction mice model.
Yu H; Zhu J; Chang L; Liang C; Li X; Wang W
Life Sci; 2021 May; 272():119206. PubMed ID: 33577854
[TBL] [Abstract][Full Text] [Related]
20. Wnt4 negatively regulates the TGF-β1-induced human dermal fibroblast-to-myofibroblast transition via targeting Smad3 and ERK.
Liu J; Zhao B; Zhu H; Pan Q; Cai M; Bai X; Li X; Hu X; Zhang M; Shi J; Zheng Z; Yang A; Hu D
Cell Tissue Res; 2020 Mar; 379(3):537-548. PubMed ID: 31776823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]